Press releases
- Ambry Genetics and PacBio Announce Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare Diseases
- PacBio Announces First Quarter 2024 Financial Results
- PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance
- Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes
- PacBio Grants Equity Incentive Award to New Employee
- PacBio Announces PureTarget™ Repeat Expansion Panel, Expanding its Portfolio of End-to-End Clinical Research Solutions
More ▼
Key statistics
On Friday, Pacific Biosciences of California Inc (P09:DUS) closed at 1.69, 39.83% above the 52 week low of 1.21 set on Apr 17, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.71 |
---|---|
High | 1.77 |
Low | 1.67 |
Bid | 1.62 |
Offer | 1.69 |
Previous close | 1.68 |
Average volume | 9.29k |
---|---|
Shares outstanding | 272.36m |
Free float | 267.26m |
P/E (TTM) | -- |
Market cap | 487.52m USD |
EPS (TTM) | -1.14 USD |
Data delayed at least 15 minutes, as of May 31 2024 18:30 BST.
More ▼